Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,521 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 851-875 of 1,000 matching filings.

Per page
25
Current page
35
424B5 File 333-193012

PROSPECTUS SUPPLEMENT

Filing date
10 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-11460

ANNUAL REPORT

Filing date
31 Mar 2014
Reporting date
31 Dec 2013
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT

Filing date
27 Mar 2014
Reporting date
27 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
14 Mar 2014
Reporting date
11 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42217

SC 13G filing

Filing date
14 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Jan 2014
Reporting date
23 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
27 Jan 2014
Reporting date
23 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
27 Jan 2014
Reporting date
23 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-193012

EFFECT filing

Filing date
09 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
06 Jan 2014
Reporting date
30 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-193012

FORM S-3

Filing date
20 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
09 Dec 2013
Reporting date
03 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-192496

NTN BUZZTIME

Filing date
09 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-192496

EFFECT filing

Filing date
05 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME, INC.

Filing date
22 Nov 2013
Reporting date
22 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-192496

S-3

Filing date
22 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-206476

D filing

Filing date
18 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-11460

QUARTERLY REPORT

Filing date
14 Nov 2013
Reporting date
30 Sep 2013
Next action
Verify source filing
8-K File 001-11460

FORM 8K

Filing date
13 Nov 2013
Reporting date
12 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
13 Nov 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT

Filing date
14 Aug 2013
Reporting date
14 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jun 2013
Reporting date
13 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jun 2013
Reporting date
13 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Jun 2013
Reporting date
13 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .